Related Experiment Videos
Somatic cell hybridization of human tumor samples
Somatic Cell and Molecular Genetics
|March 1, 1984
Summary
Researchers created hybrid tumor cell lines from various human cancers by fusing tumor cells with a resistant cell line. Optimal fusion conditions involved unfrozen tissue and 50% PEG, with minimal chromosome loss observed.
Area of Science:
- * Oncology
- * Cell Biology
- * Genetics
Background:
- * Tumorigenesis and metastasis involve complex cellular mechanisms.
- * Development of stable hybrid cell lines is crucial for cancer research.
- * The D98OR cell line offers a unique genetic marker for hybrid selection.
Purpose of the Study:
- * To establish human intraspecific hybrid cell lines from diverse tumor types.
- * To optimize fusion protocols for generating tumor-derived hybrids.
- * To characterize the genetic stability and cellular origin of the resulting hybrids.
Main Methods:
- * Fusion of tumor cells (renal, colon, melanoma, chondrosarcoma, hepatocarcinoma) with D98OR cells using polyethylene glycol (PEG).
- * Comparison of fusion efficiency using fresh versus cryopreserved tumor tissue.
- * Assessment of chromosome stability in hybrid lines via flow cytometry DNA content analysis.
Main Results:
- * Successful generation of hybrid tumor cell lines from multiple cancer types.
- * Optimal fusion achieved with unfrozen tumor tissue and 50% PEG concentration.
- * Minimal chromosome loss detected in hybrid cell lines post-fusion.
- * Hybrid cells exhibited characteristics confirming their tumor cell origin.
Conclusions:
- * Human intraspecific hybrid cell line generation is feasible across various cancers.
- * Cryopreservation and specific PEG concentrations impact fusion efficiency.
- * The developed hybrids are genetically stable and derived from malignant cells, suitable for further research.